National Pharmaceutical Pricing Authority (NPPA  will conduct the First Pharmaceutical Industry Census (FPCI to generate pharma map of India after gathering information on various aspects including investments, pricing and specifications

Drug price controller National Pharmaceutical Pricing Authority (NPPA) will conduct a nation - wide census on drug firms in the country. This will provide insights to the government for future policy making and planning.

The First Pharmaceutical Industry Census (FPCI) intends to generate pharma map of India after gathering information on various aspects including investments, pricing and product specifications, as well as compliance to good manufacturing practices by drug makers in the country.

“The proposed census would cover more than 10,000 drug manufacturing units in the country through a structured questionnaire so as to provide insights for policy making and planning. NPPA would publish the census data and would send it to various ministries for their reference and future actions,” said Ashok Kumar, chairman, NPPA.
He said the government has allocated Rs54 lakh in the phase I for conducting the census. NPPA would conduct the census in association with 4th All India Census of Micro, Small and Medium Enterprises.

Chemicals and Fertilisers Minister Ram Vilas Paswan, who was presiding over an NPPA function, said that FPCI would commence during the current fiscal and would be concluded during the next fiscal. He said the census would create a database regarding turnover of pharmaceutical manufacturing units in the country by class of industry, state-wise and district wise and by type of units (formulation and bulk among others).